2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 129 filers reported holding 2SEVENTY BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,889 | -98.4% | 3,543 | -95.9% | 0.00% | -100.0% |
| Q2 2023 | $864,754 | -67.8% | 85,450 | -67.5% | 0.00% | -50.0% |
| Q1 2023 | $2,682,355 | +343.3% | 262,976 | +307.3% | 0.00% | – |
| Q4 2022 | $605,049 | -65.2% | 64,573 | -46.0% | 0.00% | -100.0% |
| Q3 2022 | $1,741,000 | +46.5% | 119,664 | +33.0% | 0.00% | 0.0% |
| Q2 2022 | $1,188,000 | +85.9% | 90,003 | +140.3% | 0.00% | – |
| Q1 2022 | $639,000 | -82.5% | 37,460 | -73.8% | 0.00% | -100.0% |
| Q4 2021 | $3,659,000 | – | 142,755 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newtyn Management, LLC | 1,587,805 | $27,088,000 | 6.49% |
| CHI Advisors LLC | 819,672 | $13,984,000 | 5.95% |
| Madison Avenue Partners, LP | 896,972 | $15,302,342,000 | 2.86% |
| Bain Capital Life Sciences Investors, LLC | 1,408,901 | $24,036,000 | 2.33% |
| EcoR1 Capital, LLC | 3,495,943 | $59,641,000 | 1.87% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $5,118,000 | 1.02% |
| CVI Holdings, LLC | 819,672 | $13,984,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 2,000,000 | $34,120,000 | 0.66% |
| Altium Capital Management LP | 115,000 | $1,962,000 | 0.66% |
| Casdin Capital, LLC | 614,754 | $10,488,000 | 0.47% |